A geographical cluster randomised stepped wedge study of continuing medical education and cancer diagnosis in general practice

Berit Skjødeberg Toftegaard, Flemming Bro, Peter Vedsted, Berit Skjødeberg Toftegaard, Flemming Bro, Peter Vedsted

Abstract

Background: Denmark has inferior cancer survival rates compared with many European countries. The main reason for this is suggested to be late diagnosis at advanced cancer stages. Cancer diagnostic work-up begins in general practice in 85% of all cancer cases. Thus, general practitioners (GPs) play a key role in the diagnostic process. The latest Danish Cancer Plan included continuing medical education (CME) on early cancer diagnosis in general practice to improve early diagnosis. This dual aims of this protocol are, first, to describe the conceptualisation, operationalisation and implementation of the CME and, second, to describe the study design and outcomes chosen to evaluate the effects of the CME.

Methods/design: The intervention is a CME in early cancer diagnosis targeting individual GPs. It was developed by a step-wise approach. Barriers for early cancer diagnosis at GP level were identified systematically and analysed using the behaviour system involving capability, opportunity and motivation described by Michie et al. The study will be designed as a geographical cluster randomised stepped wedge study. The study population counts 836 GPs from 417 general practices in the Central Denmark Region, geographically divided into eight clusters. GPs from each cluster will be invited to a CME meeting at a certain date three weeks apart. The primary outcomes will be primary care interval and GP referral rate on cancer suspicion. Data will be obtained from national registries, GP-completed forms on patients referred to cancer fast-track pathways and GP-completed online questionnaires before and after the intervention.

Discussion: To our knowledge, this will be the first study to measure the effect of a theory-based CME in early cancer diagnosis at three levels: GP knowledge and attitude, GP activity and patient outcomes. The achieved knowledge will contribute to the understanding of whether and how general practice's ability to perform cancer diagnosis may be improved.

Trial registration: Registered as NCT02069470 on ClinicalTrials.gov.

Figures

Figure 1
Figure 1
The process of identifying the important barriers to be included in the CME program.
Figure 2
Figure 2
The stepped wedge design to evaluate the effect of the CME. The first time point to the left indicates the baseline measurement where all of the clusters were controls (C). At subsequent time points, clusters received the CME intervention and crossed over to interventions (I). All clusters eventually received the intervention. The bottom of the figure focuses on one cluster to illustrate the data collection and the three subgroups for stratification: 1) GPs who participated in the CME; 2) GPs who did not participate in the CME, but who had at least one colleague who participated; 3) GPs who did not participate in the CME and who had no colleagues who participated.
Figure 3
Figure 3
The aspects of the interventions that were measured and the outcomes. The first column depicts the elements in the change process; the second column classifies the corresponding outcomes; the third column describes the methods applied; and the fourth column depicts the data sources.

References

    1. Coleman M, Forman D, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, McGahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward J, Richards MA, ICBP Module 1 Working Group Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the international cancer benchmarking partnership): An analysis of population-based cancer registry data. Lancet. 2011;377(9760):127–138. doi: 10.1016/S0140-6736(10)62231-3.
    1. Butler J, Foot C, Bomb M, Hiom S, Coleman M, Bryant H, Vedsted P, Hanson J, Richards M, ICBP Working Group The international cancer benchmarking partnership: An international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom. Health Policy. 2013;112(1–2):148–155. doi: 10.1016/j.healthpol.2013.03.021.
    1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–1403. doi: 10.1016/j.ejca.2012.12.027.
    1. Walters S, Maringe C, Butler J, Rachet B, Barrett-Lee P, Bergh J, Boyages J, Christiansen P, Lee M, Wärnberg F, Allemani C, Engholm G, Fornander T, Gjerstorff ML, Johannesen TB, Lawrence G, McGahan CE, Middleton R, Steward J, Tracey E, Turner D, Richards MA, Coleman MP, ICBP Module 1 Working Group Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000–2007: A population-based study. Br J Cancer. 2013;108(5):1195–1208. doi: 10.1038/bjc.2013.6.
    1. Walters S, Maringe C, Coleman MP, Peake MD, Butler J, Young N, Bergström S, Hanna L, Jakobsen E, Kölbeck K, Sundstrøm S, Engholm G, Gavin A, Gjerstorff ML, Hatcher J, Johannesen TB, Linklater KM, McGahan CE, Steward J, Tracey E, Turner D, Richards MA, Rachet B, the ICBP Module 1 Working Group Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: A population-based study, 2004–2007. Thorax. 2013;68(6):551–564. doi: 10.1136/thoraxjnl-2012-202297.
    1. Maringe C, Walters S, Rachet B, Butler J, Fields T, Finan P, Maxwell R, Nedrebø B, Påhlman L, Sjövall A, Spigelman A, Engholm G, Gavin A, Gjerstorff ML, Hatcher J, Johannesen TB, Morris E, McGahan CE, Tracey E, Turner D, Richards MA, Coleman MP, ICBP Module 1 Working Group Stage at diagnosis and colorectal cancer survival in six high-income countries: A population-based study of patients diagnosed during 2000–2007. Acta Oncol. 2013;52(5):919–932. doi: 10.3109/0284186X.2013.764008.
    1. Maringe C, Walters S, Butler J, Coleman MP, Hacker N, Hanna L, Mosgaard BJ, Nordin A, Rosen B, Engholm G, Gjerstorff ML, Hatcher J, Johannesen TB, McGahan CE, Meechan D, Middleton R, Tracey E, Turner D, Richards MA, Rachet B, ICBP Module 1 Working Group Stage at diagnosis and ovarian cancer survival: Evidence from the international cancer benchmarking partnership. Gynecol Oncol. 2012;127(1):75–82. doi: 10.1016/j.ygyno.2012.06.033.
    1. Torring ML, Frydenberg M, Hansen RP, Olesen F, Vedsted P. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: A cohort study in primary care. Eur J Cancer. 2013;49(9):2187–2198. doi: 10.1016/j.ejca.2013.01.025.
    1. Neal RD. Do diagnostic delays in cancer matter? Br J Cancer. 2009;101(Suppl 2):9–12. doi: 10.1038/sj.bjc.6605384.
    1. Probst HB, Hussain ZB, Andersen O. Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians-A national Danish project. Health Policy. 2012;105(1):65–70. doi: 10.1016/j.healthpol.2011.11.001.
    1. Dyrop HB, Safwat A, Vedsted P, Maretty-Nielsen K, Hansen BH, Jorgensen PH, Baad-Hansen T, Bünger C, Keller J. Cancer patient pathways shortens waiting times and accelerates the diagnostic process of suspected sarcoma patients in denmark. Health Policy. 2013;113(1–2):110–117. doi: 10.1016/j.healthpol.2013.09.012.
    1. O'Donnell CA. Variation in GP referral rates: What can we learn from the literature? Fam Pract. 2000;17(6):462–471. doi: 10.1093/fampra/17.6.462.
    1. Hansen RP, Vedsted P, Sokolowski I, Sondergaard J, Olesen F. General practitioner characteristics and delay in cancer diagnosis. A population-based cohort study. BMC Fam Pract. 2011;12:100. doi: 10.1186/1471-2296-12-100.
    1. Christensen CG, Fenger-Grøn M, Flarup KR, Vedsted P. Use of general practice, diagnostic investigations and hospital services before and after cancer diagnosis - a population-based nationwide registry study of 127,000 incident adult cancer patients. BMC Health Serv Res. 2012;12:224. doi: 10.1186/1472-6963-12-224.
    1. Hansen RP, Vedsted P, Sokolowski I, Sondergaard J, Olesen F. Time intervals from first symptom to treatment of cancer: A cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res. 2011;11:284. doi: 10.1186/1472-6963-11-284.
    1. Weller D, Vedsted P, Rubin G, Walter FM, Emery J, Scott S, Campbell C, Andersen RS, Hamilton W, Olesen F, Rose P, Nafees S, van Rijswijk E, Hiom S, Muth C, Beyer M, Neal RD. The Aarhus statement: Improving design and reporting of studies on early cancer diagnosis. Br J Cancer. 2012;106:1262–1267. doi: 10.1038/bjc.2012.68.
    1. Dommett RM, Redaniel MT, Stevens MC, Hamilton W, Martin RM. Features of childhood cancer in primary care: A population-based nested case–control study. Br J Cancer. 2012;106:982–987. doi: 10.1038/bjc.2011.600.
    1. Emery JD, Shaw K, Williams B, Mazza D, Fallon-Ferguson J, Varlow M, Trevena LJ. The role of primary care in early detection and follow-up of cancer. Nat Rev Clin Oncol. 2014;11:38–48. doi: 10.1038/nrclinonc.2013.212.
    1. Hamilton W, Roobottom C. Early diagnosis of cancer by imaging: The primary care perspective. Radiography. 2011;18:5–8. doi: 10.1016/j.radi.2011.10.002.
    1. Hamilton W. Cancer diagnosis in primary care. Br J Gen Pract. 2010;60(571):121–128. doi: 10.3399/bjgp10X483175.
    1. Hamilton W, Vedsted P. Cancer and primary care: The clinical and research agenda. Br J Gen Pract. 2011;61(592):653–654. doi: 10.3399/bjgp11X601523.
    1. Hamilton W. The CAPER studies: Five case–control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. Br J Cancer. 2009;101(Suppl 2):80–86. doi: 10.1038/sj.bjc.6605396.
    1. Hamilton W, Peters TJ, Round A, Sharp D. What are the clinical features of lung cancer before the diagnosis is made? A population based case–control study. Thorax. 2005;60(12):1059–1065. doi: 10.1136/thx.2005.045880.
    1. Hamilton W, Round A, Sharp D, Peters TJ. Clinical features of colorectal cancer before diagnosis: A population-based case–control study. Br J Cancer. 2005;93(4):399–405. doi: 10.1038/sj.bjc.6602714.
    1. Hamilton W, Sharp DJ, Peters TJ, Round AP. Clinical features of prostate cancer before diagnosis: A population-based, case–control study. Br J Gen Pract. 2006;56(531):756–762.
    1. Hamilton W, Kernick D. Clinical features of primary brain tumours: A case–control study using electronic primary care records. Br J Gen Pract. 2007;57(542):695–699.
    1. Hamilton W, Peters TJ, Bankhead C, Sharp D. Risk of ovarian cancer in women with symptoms in primary care: Population based case–control study. BMJ. 2009;339:b2998. doi: 10.1136/bmj.b2998.
    1. Hamilton W, Green T, Martins T, Elliott K, Rubin G, Macleod U. Evaluation of risk assessment tools for suspected cancer in general practice: A cohort study. Br J Gen Pract. 2013;63(606):e30–e36. doi: 10.3399/bjgp13X660751.
    1. Hippisley-Cox J, Coupland C. Symptoms and risk factors to identify men with suspected cancer in primary care: Derivation and validation of an algorithm. Br J Gen Pract. 2013;63(606):e1–e10. doi: 10.3399/bjgp13X660724.
    1. Hippisley-Cox J, Coupland C. Symptoms and risk factors to identify women with suspected cancer in primary care: Derivation and validation of an algorithm. Br J Gen Pract. 2013;63(606):e11–e21. doi: 10.3399/bjgp13X660733.
    1. Guldbrandt LM, Rasmussen TR, Rasmussen F, Vedsted P: Implementing direct access to chest computed tomography in general practice – method, adaption and outcome. PlosOne, in press.
    1. Meechan D, Gildea C, Hollingworth L, Richards MA, Riley D, Rubin G. Variation in use of the 2-week referral pathway for suspected cancer: A cross-sectional analysis. Br J Gen Pract. 2012;62(602):590–597. doi: 10.3399/bjgp12X654551.
    1. Pedersen KM, Andersen JS, Sondergaard J. General practice and primary health care in Denmark. J Am Board Fam Med. 2012;25(Suppl 1):34–38. doi: 10.3122/jabfm.2012.02.110216.
    1. Grol R, Wensing M, Bosch M, Hulscher M and Eccles M. Theories on implementation of change in healthcare, in Improving Patient Care: The Implementation of Change in Health Care. 2nd edition. Edited by Grol R, Wensing M, Eccles M, Davis D. Oxford: John Wiley & Sons; 2013
    1. Morgan DL, Bottorff JL. Advancing our craft: Focus group methods and practice. Qual Health Res. 2010;20(5):579–581. doi: 10.1177/1049732310364625.
    1. Mitchell ED, Rubin G, Macleod U. Understanding diagnosis of lung cancer in primary care: Qualitative synthesis of significant event audit reports. Br J Gen Pract. 2013;63(606):e37–e46. doi: 10.3399/bjgp13X660760.
    1. Rose PW, Hamilton W, Aldersey K, Barisic A, Dawes M, Foot C, Grunfeld E, Hart N, Neal RD, Pirotta M, Sisler J, Thulesius H, Vedsted P, Young J, Rubin G, The ICBP Module 3 Working Group Development of a survey instrument to investigate the primary care factors related to differences in cancer diagnosis between international jurisdictions. BMC Fam Pract. 2014;15:122. doi: 10.1186/1471-2296-15-122.
    1. Jones R, Latinovic R, Charlton J, Gulliford MC. Alarm symptoms in early diagnosis of cancer in primary care: Cohort study using general practice research database. BMJ. 2007;334(7602):1040. doi: 10.1136/.
    1. Nielsen TN, Hansen RP, Vedsted P. Symptom presentation in cancer patients in general practice. Ugeskr Laeger. 2010;172:2827–2831.
    1. Hamilton W. Five misconceptions in cancer diagnosis. Br J Gen Pract. 2009;59(563):441–445. doi: 10.3399/bjgp09X420860.
    1. Jensen AR, Nellemann HM, Overgaard J. Tumor progression in waiting time for radiotherapy in head and neck cancer. Radiother Oncol. 2007;84(1):5–10. doi: 10.1016/j.radonc.2007.04.001.
    1. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: A systematic review. Lancet. 1999;353(9159):1119–1126. doi: 10.1016/S0140-6736(99)02143-1.
    1. Stapley S, Sharp D, Hamilton W. Negative chest X-rays in primary care patients with lung cancer. Br J Gen Pract. 2006;56(529):570–573.
    1. Jensen H, Nissen A, Vedsted P. Quality deviations in cancer diagnosis: Prevalence and time to diagnosis in general practice. Br J Gen Pract. 2014;64(619):e92–e98. doi: 10.3399/bjgp14X677149.
    1. Vedsted P, Olesen F. Are the serious problems in cancer survival partly rooted in gatekeeper principles? An ecologic study. Br J Gen Pract. 2011;61(589):508–512. doi: 10.3399/bjgp11X588484.
    1. Michie S, van Stralen MM, West R. The behaviour change wheel: A new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42. doi: 10.1186/1748-5908-6-42.
    1. Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer. 1999;79(5):858–864. doi: 10.1038/sj.bjc.6690137.
    1. Schichtel M, Rose PW, Sellers C. Educational interventions for primary healthcare professionals to promote the early diagnosis of cancer: A systematic review. Educ Prim Care. 2013;24(4):274–290.
    1. Forsetlund L, Bjorndal A, Rashidian A, Jamtvedt G, O'Brien MA, Wolf F, Davis D, Odgaard-Jensen J, Oxman AD: Continuing education meetings and workshops: Effects on professional practice and health care outcomes.Cochrane Database Syst Rev 2009, Issue 2. Art. No.:CD003030
    1. Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials. 2007;28(2):182–191. doi: 10.1016/j.cct.2006.05.007.
    1. Jørgensen CK, Karlsmose B. Validation of automated forms processing. A comparison of TeleformT with manual data entry. Comput Biol Med. 1998;28(6):659–667. doi: 10.1016/S0010-4825(98)00038-9.
    1. Lidegaard O, Hammerum MS. The National Patient Registry as a tool for continuous production and quality control. Ugeskr Laeger. 2002;164(38):4420–4423.
    1. Olivarius NF, Hollnagel H, Krasnik A, Pedersen PA, Thorsen H. The Danish National Health Register. A tool for primary health care research. Dan Med Bull. 1997;44(4):449–453.
    1. Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health. 2011;39(7):42–45. doi: 10.1177/1403494810393562.
    1. Statistics Denmark. []
    1. Jensen H, Torring ML, Larsen MB, Vedsted P. Existing data sources for clinical epidemiology: Danish cancer in primary care cohort. Clin Epidemiol. 2014;6:237–246. doi: 10.2147/CLEP.S62855.
    1. Woertman W, de Hoop E, Moerbeek M, Zuidema SU, Gerritsen DL, Teerenstra S. Stepped wedge designs could reduce the required sample size in cluster randomized trials. J Clin Epidemiol. 2013;66(7):752–758. doi: 10.1016/j.jclinepi.2013.01.009.
    1. Machin D, Campbell MJ, Tan SB, Tan SH. Sample Size Tables for Clinical Studies. 3. Oxford: John Wiley & Sons; 2009. p. 59.
    1. Jensen H, Torring ML, Olesen F, Overgaard J, Vedsted P. Cancer suspicion in general practice, urgent referral and time to diagnosis: A population-based GP survey and registry study. BMC Cancer. 2014;14(1):636. doi: 10.1186/1471-2407-14-636.

Source: PubMed

3
订阅